EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Natural Versus Vaccine-Induced Immunity Against HPV: A Comparative Review of Antibody Response and Cancer Prevention

Bogdan Ghilencea, Bianca Ilinca Moroianu, Ancuța-Iuliana Năstac iD, Ioana-Stefania Bostan, Anca Panaitescu iD, Claudia Mehedințu, Nicolae Gică iD

Antibodies · 13.07.2026 · 15 (4) · 61

DOI: 10.3390/antib15040061 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antibodies, online erschienen am 13.07.2026. Verfasst von Bogdan Ghilencea und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050471 Bucharest, Romania. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human Papillomavirus (HPV) infection is the leading cause of cervical cancer, presenting a significant global health challenge. While natural infection is widespread, the resulting immune response is often characterized by weak, delayed, and type-specific antibody production, offering unreliable protection against reinfection. This review provides a comparative analysis of natural versus vaccine-induced immunity, focusing on antibody kinetics, duration of protection, and cancer prevention efficacy. A comprehensive search of the literature from the last decade was conducted using PubMed, ScienceDirect, and Web of Science. The findings demonstrate that, unlike natural immunity, which is dominated by cellular responses with often incomplete seroconversion, prophylactic vaccination induces high titers of neutralizing IgG antibodies against the L1 capsid protein. These responses are durable, with protection persisting for over a decade, and recent data support the high efficacy of single-dose regimens. Furthermore, vaccination has shown utility in reducing infection persistence in HPV-positive individuals and provides critical protection in immunocompromised groups. Consequently, vaccine-induced immunity is consistently superior to naturally acquired immunity, supporting World Health Organization recommendations for universal vaccination as the primary intervention for reducing the global burden of HPV-related malignancies.

Schlagwörter

Stichwörter der Autor:innen

HPVantibodiescancer preventionimmunityvaccination

Autor:innen und Institutionen

  • Faculty of Medicine, "Carol Davila" University of Medicine and Pharmacy, 050471 Bucharest, Romania.
  • Department of Obstetrics and Gynecology, Filantropia Clinical Hospital, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

ORCID-Profile: Ancuța-Iuliana Năstac, Anca Panaitescu, Nicolae Gică

Zitieren

APA

Ghilencea, B., Moroianu, B. I., Năstac, A. I., Bostan, I. S., Panaitescu, A., Mehedințu, C., & Gică, N. (2026). Natural Versus Vaccine-Induced Immunity Against HPV: A Comparative Review of Antibody Response and Cancer Prevention. Antibodies, 15(4), 61. https://doi.org/10.3390/antib15040061

Vancouver

Ghilencea B, Moroianu BI, Năstac AI, Bostan IS, Panaitescu A, Mehedințu C, et al. Natural Versus Vaccine-Induced Immunity Against HPV: A Comparative Review of Antibody Response and Cancer Prevention. Antibodies. 2026;15(4):61. doi:10.3390/antib15040061

BibTeX
@article{Ghilencea2026,
  author = {Ghilencea, Bogdan and Moroianu, Bianca Ilinca and Năstac, Ancuța-Iuliana and Bostan, Ioana-Stefania and Panaitescu, Anca and Mehedințu, Claudia and Gică, Nicolae},
  title = {Natural Versus Vaccine-Induced Immunity Against HPV: A Comparative Review of Antibody Response and Cancer Prevention},
  journal = {Antibodies},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {61},
  doi = {10.3390/antib15040061}
}
Kostenlos starten →